Is Repligen Stock a Good Investment?

Repligen Investment Advice

RGEN

To provide specific investment advice or recommendations on Repligen stock, we recommend investors consider the following general factors when evaluating Repligen. This will help you to make an informed decision on whether to include Repligen in one of your diversified portfolios:

Examine Repligen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Repligen's leadership team and their track record. Good management can help Repligen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Repligen's business and its evolving consumer preferences.
Compare Repligen's performance and market position to its competitors. Analyze how Repligen is positioned in terms of product offerings, innovation, and market share.
Check if Repligen pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Repligen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Repligen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Repligen is a good investment.

Sell

Buy

Sell

Macroaxis provides advice on Repligen to complement and cross-verify current analyst consensus on Repligen. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Repligen is not overpriced, please check all Repligen fundamentals, including its revenue, cash flow from operations, working capital, as well as the relationship between the cash per share and number of employees . Given that Repligen has a price to earning of 154.58 X, we recommend you to check out Repligen market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance	Weak	Details
Volatility	Very steady	Details
Hype Condition	Stale	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Almost mirrors the market	Details
Investor Sentiment	Interested	Details
Analyst Consensus	Strong Buy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Repligen Stock

Researching Repligen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 94.0% of the company shares are owned by institutional investors. The book value of Repligen was at this time reported as 36.65. The company has Price/Earnings To Growth (PEG) ratio of 2.59. Repligen recorded a loss per share of 0.26. The entity last dividend was issued on the 29th of October 2010.

To determine if Repligen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Repligen's research are outlined below:

	The company reported the previous year's revenue of 634.44 M. Net Loss for the year was (25.51 M) with profit before overhead, payroll, taxes, and interest of 343.65 M.
	Over 94.0% of the company shares are owned by institutional investors
	Latest headline from finance.yahoo.com: Do Options Traders Know Something About Repligen Stock We Dont

Repligen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Repligen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Repligen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	28th of February 2024 Upcoming Quarterly Report	View
	7th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	28th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Repligen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Repligen's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2017-02-22	2016-12-31	0.07	0.08	0.01	14
2010-06-09	2010-03-31	-0.04	-0.05	-0.01	25
2009-11-05	2009-09-30	-0.04	-0.03	0.01	25
2006-11-02	2006-09-30	-0.02	-0.03	-0.01	50
2006-02-09	2005-12-31	-0.02	-0.01	0.01	50
2004-02-11	2003-12-31	-0.08	-0.07	0.01	12
2007-06-07	2007-03-31	-0.02	-0.0035	0.0165	82
2007-02-08	2006-12-31	-0.02	-6.0E-4	0.0194	97

Know Repligen's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Repligen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Repligen backward and forwards among themselves. Repligen's institutional investor refers to the entity that pools money to purchase Repligen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Brown Capital Management, Llc	2025-06-30	1 M
Geode Capital Management, Llc	2025-03-31	991.6 K
Conestoga Capital Advisors, Llc	2025-06-30	976.9 K
Holocene Advisors, Lp	2025-03-31	960 K
Macquarie Group Ltd	2025-03-31	910 K
Dimensional Fund Advisors, Inc.	2025-06-30	768 K
Impax Asset Management Group Plc	2025-06-30	761 K
Fmr Inc	2025-03-31	732.4 K
Ameriprise Financial Inc	2025-03-31	685 K
Blackrock Inc	2025-03-31	6.8 M
T. Rowe Price Associates, Inc.	2025-06-30	6.6 M

Note, although Repligen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Repligen's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.73 B.

Market Cap

13.77 Billion

Repligen's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.02)	(0.02)
Return On Capital Employed	(0.01)	(0.01)
Return On Assets	(0.01)	(0.01)
Return On Equity	(0.01)	(0.01)

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.

Determining Repligen's profitability involves analyzing its financial statements and using various financial metrics to determine if Repligen is a good buy. For example, gross profit margin measures Repligen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Repligen's profitability and make more informed investment decisions.

Repligen's Earnings Breakdown by Geography

Evaluate Repligen's management efficiency

Repligen has return on total asset (ROA) of 0.0113 % which means that it generated a profit of $0.0113 on every $100 spent on assets. This is way below average. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of August 2025, Return On Tangible Assets is likely to drop to -0.02. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Repligen's Net Tangible Assets are very stable compared to the past year. As of the 22nd of August 2025, Asset Turnover is likely to grow to 0.30, while Intangible Assets are likely to drop about 242.7 M.

	Last Reported	Projected for Next Year
Book Value Per Share	35.27	37.03
Tangible Book Value Per Share	9.72	10.21
Enterprise Value Over EBITDA	97.20	102.06
Price Book Value Ratio	4.08	3.88
Enterprise Value Multiple	97.20	102.06
Price Fair Value	4.08	3.88
Enterprise Value	12.9 B	13.5 B

Repligen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.

Beta

1.052

Basic technical analysis of Repligen Stock

As of the 22nd of August, Repligen holds the Coefficient Of Variation of 52488.08, risk adjusted performance of 0.0088, and Semi Deviation of 2.79. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them.

Repligen's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repligen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repligen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Repligen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Anthony Hunt over two months ago Disposition of 10723 shares by Anthony Hunt of Repligen at 145.95 subject to Rule 16b-3
		Jason Garland over three months ago Acquisition by Jason Garland of 6435 shares of Repligen subject to Rule 16b-3
		Anthony Hunt over three months ago Disposition of 13057 shares by Anthony Hunt of Repligen at 192.71 subject to Rule 16b-3
		James Bylund over three months ago Disposition of 175 shares by James Bylund of Repligen at 142.44 subject to Rule 16b-3
		Anthony Hunt over three months ago Disposition of 2380 shares by Anthony Hunt of Repligen at 164.74 subject to Rule 16b-3
		Anthony Hunt over three months ago Disposition of 2825 shares by Anthony Hunt of Repligen at 156.54 subject to Rule 16b-3
		Anthony Hunt over three months ago Disposition of 2825 shares by Anthony Hunt of Repligen at 156.54 subject to Rule 16b-3
		Anthony Hunt over six months ago Disposition of 9369 shares by Anthony Hunt of Repligen at 144.88 subject to Rule 16b-3
		Anthony Hunt over six months ago Acquisition by Anthony Hunt of 10000 shares of Repligen at 33.87 subject to Rule 16b-3
		Dawes Karen A over a year ago Acquisition by Dawes Karen A of 2953 shares of Repligen at 67.71 subject to Rule 16b-3
		Muir Glenn P over a year ago Acquisition by Muir Glenn P of 1376 shares of Repligen at 171.03 subject to Rule 16b-3
		James Bylund over a year ago Disposition of 444 shares by James Bylund of Repligen at 182.95 subject to Rule 16b-3

Repligen's Outstanding Corporate Bonds

Repligen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Repligen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Repligen bonds can be classified according to their maturity, which is the date when Repligen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View

View All Repligen Corporate Bonds

Understand Repligen's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Repligen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0088
	Market Risk Adjusted Performance	0.0075
	Mean Deviation	2.12
	Semi Deviation	2.79
	Downside Deviation	2.84
	Coefficient Of Variation	52488.08
	Standard Deviation	2.82
	Variance	7.92
	Information Ratio	(0.04)
	Jensen Alpha	(0.18)
	Total Risk Alpha	(0.36)
	Sortino Ratio	(0.03)
	Treynor Ratio	(0)
	Maximum Drawdown	11.72
	Value At Risk	(4.70)
	Potential Upside	4.72
	Downside Variance	8.06
	Semi Variance	7.8
	Expected Short fall	(2.13)
	Skewness	0.1241
	Kurtosis	0.7292

	Risk Adjusted Performance	0.0088
	Market Risk Adjusted Performance	0.0075
	Mean Deviation	2.12
	Semi Deviation	2.79
	Downside Deviation	2.84
	Coefficient Of Variation	52488.08
	Standard Deviation	2.82
	Variance	7.92
	Information Ratio	(0.04)
	Jensen Alpha	(0.18)
	Total Risk Alpha	(0.36)
	Sortino Ratio	(0.03)
	Treynor Ratio	(0)
	Maximum Drawdown	11.72
	Value At Risk	(4.70)
	Potential Upside	4.72
	Downside Variance	8.06
	Semi Variance	7.8
	Expected Short fall	(2.13)
	Skewness	0.1241
	Kurtosis	0.7292

Consider Repligen's intraday indicators

Repligen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Repligen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	44560.72
	Daily Balance Of Power	0.7031
	Rate Of Daily Change	1.04
	Day Median Price	123.56
	Day Typical Price	123.97
	Price Action Indicator	3.81
	Period Momentum Indicator	5.14
	Relative Strength Index	53.25

Repligen Corporate Filings

F4	12th of August 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
10Q	7th of August 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
8K	29th of July 2025 Report filed with the SEC to announce major events that shareholders should know about	View Verify
	24th of April 2025 Other Reports	View Verify

Repligen time-series forecasting models is one of many Repligen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repligen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Repligen Stock media impact

There is far too much social signal, news, headlines, and media speculation about Repligen that are available to investors today. This information is accessible both publicly - through Repligen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Repligen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.

A primary focus of Repligen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repligen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repligen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repligen alpha.

Repligen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repligen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Repligen Historical Investor Sentiment

Investor biases related to Repligen's public news can be used to forecast risks associated with an investment in Repligen. The trend in average sentiment can be used to explain how an investor holding Repligen can time the market purely based on public headlines and social activities around Repligen. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Repligen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Repligen and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Repligen news discussions. The higher the estimate score, the more favorable the investor's outlook on Repligen.

Repligen Maximum Pain Price Across November 21st 2025 Option Contracts

Repligen's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Repligen close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Repligen's options.

Repligen Corporate Management

Christine Gebski	Senior Chromatography	Profile
Kimberly Cornwell	General Counsel	Profile
Dianne Heiler	Senior Sustainability	Profile
James Bylund	Chief Officer	Profile
Kola Otitoju	Senior Development	Profile
Stephen Tingley	VP Sales	Profile
Jaime Humara	Senior Marketing	Profile

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock: